Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of SS-001 ointment for chemotherapy-induced hand-foot syndrome
CTR20254038Phase 2Completed
- Sponsor
- Suzhou Merna Therapeutics
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SS-001 in Erythrodysesthesia syndrome (PPE), sponsored by Suzhou Merna Therapeutics. Started Oct 2025; status: completed.
02
Drugs
SS-001
03
Conditions
Erythrodysesthesia syndrome (PPE)
Beyond the preview
Go deeper on CTR20254038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254038.